CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 22 of 48

Rheumatology (Oxford)

Briefs 841–880 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Long-term effectiveness of the combination of iguratimod and alendronate in SAPHO syndrome: a prospective cohort study

    Cohort studyOsteoporosis

  2. Rheumatology (Oxford)

    Prognostic factors for patients with cancer-associated dermatomyositis: a retrospective, multicentre cohort study of 73 patients

    Cohort studyMyositis

  3. Rheumatology (Oxford)

    Pulmonary involvement in systemic sclerosis: can sex play a role?

    Cohort studySystemic sclerosis

  4. Rheumatology (Oxford)

    68Ga-FAPI and 18F-NaF PET/CT in psoriatic arthritis: a comparative study

    Diagnostic or prognostic studySpondyloarthritis & PsA

  5. Rheumatology (Oxford)

    Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort

    Randomized controlled trialRA

  6. Rheumatology (Oxford)

    A mobile app to support self-management and remotely monitor disease impact in rheumatoid arthritis: the randomized controlled AEGORA trial

    Randomized controlled trialRA

  7. Rheumatology (Oxford)

    Enhancing diagnosis of gout with deep learning in dual-energy computed tomography: a retrospective analysis of crystal and artefact differentiation

    Diagnostic or prognostic studyGout & crystals

  8. Rheumatology (Oxford)

    Type I interferon biomarker in idiopathic inflammatory myopathies: associations of Siglec-1 with disease activity and treatment response

    Secondary analysisMyositis

  9. Rheumatology (Oxford)

    Association between antiphospholipid antibodies and diffuse alveolar haemorrhage risk in systemic lupus erythematosus: a systematic review and meta-analysis

    Meta-analysisLupus & APS

  10. Rheumatology (Oxford)

    Cell-integrated serum-induced signalling patterns can differentiate between hand and knee osteoarthritis patients

    Cross-sectional studyOsteoarthritis

  11. Rheumatology (Oxford)

    Clinical course of paediatric-onset Behçet’s disease in young adulthood

    Cohort studyPediatric

  12. Rheumatology (Oxford)

    Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus

    Cross-sectional studyRA

  13. Rheumatology (Oxford)

    Anti-Sp4 and anti-CCAR1 autoantibodies in UK vs US patients with adult and juvenile-onset anti-TIF1γ-positive myositis

    Cross-sectional studyMyositis

  14. Rheumatology (Oxford)

    Association between depression and anxiety and inability to achieve remission in rheumatoid arthritis and psoriatic arthritis

    Cohort studyRA

  15. Rheumatology (Oxford)

    An artificial intelligence-based gout management system reduced chronic kidney disease incident and improved target serum urate achievement

    Cohort studyGout & crystals

  16. Rheumatology (Oxford)

    MUC5B promoter variant and survival in rheumatoid arthritis-associated interstitial lung disease

    Cohort studyRA

  17. Rheumatology (Oxford)

    Predictors of the effectiveness of first-line CTLA4-Ig in patients with RA: the FIRST registry

    Cohort studyRA

  18. Rheumatology (Oxford)

    Male fertility is preserved following ixekizumab treatment—a real-life pilot study

    Cohort studySpondyloarthritis & PsA

  19. Rheumatology (Oxford)

    QRISK3 and SCORE2 are equally reliable predictors of carotid plaques in patients with systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  20. Rheumatology (Oxford)

    Telitacicept add-on therapy in refractory idiopathic inflammatory myopathy: insights from a pilot study

    Research articleMyositis

  21. Rheumatology (Oxford)

    Impact of structural severity on outcomes in knee osteoarthritis: an analysis of data from phase 2 and phase 3 lorecivivint clinical trials

    Secondary analysisOsteoarthritis

  22. Rheumatology (Oxford)

    Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort study

    Cohort studyRA

  23. Rheumatology (Oxford)

    Neutrophil-to-lymphocyte ratio as a biomarker for clinical response after autologous haematopoietic stem cell transplantation in systemic sclerosis

    Cohort studySystemic sclerosis

  24. Rheumatology (Oxford)

    Comparative effects of biological and targeted synthetic DMARDs on incident chronic kidney disease in patients with rheumatoid arthritis

    Cohort studyRA

  25. Rheumatology (Oxford)

    Combined radiographic and US evaluations to decipher joint involvement in the hands of patients with SSc

    Cross-sectional studySystemic sclerosis

  26. Rheumatology (Oxford)

    Healthcare utilization in general practice and hospitals preceding a diagnosis of systemic sclerosis: a nationwide registry study

    Cohort studySystemic sclerosis

  27. Rheumatology (Oxford)

    High serum levels of CXCL13 predict lower response to csDMARDs in both ACPA-positive and ACPA-negative early rheumatoid arthritis

    Cohort studyRA

  28. Rheumatology (Oxford)

    Lymphadenopathy in systemic lupus erythematosus: no microbial trigger found by shotgun metagenomics in a retrospective study on 38 patients

    Cohort studyLupus & APS

  29. Rheumatology (Oxford)

    Predictors of irreversible renal dysfunction in patients with idiopathic retroperitoneal fibrosis

    Diagnostic or prognostic studyAutoinflammatory & rare

  30. Rheumatology (Oxford)

    Anti-peptide antibodies, anti-SNRK and anti-HUWE1 antibodies as potential predictors of good response to tofacitinib therapy in rheumatoid arthritis patients

    Diagnostic or prognostic studyRA

  31. Rheumatology (Oxford)

    Immunogenicity to herpes zoster recombinant subunit vaccine in immune-mediated rheumatic patients under treatment with JAK inhibitors

    Cohort studyAcross diseases

  32. Rheumatology (Oxford)

    Fatigue levels and associated factors in systemic sclerosis: a cross-sectional study of 2385 SPIN Cohort participants

    Cross-sectional studySystemic sclerosis

  33. Rheumatology (Oxford)

    Impact of baseline proteinuria level on long-term outcomes in lupus nephritis

    Cohort studyLupus & APS

  34. Rheumatology (Oxford)

    The place of JAK inhibitors in systemic juvenile idiopathic arthritis with lung disease: French experience

    Cohort studyPediatric

  35. Rheumatology (Oxford)

    Prevalence and clinical value of autoantibodies directed against lysobisphosphatidic acid in antiphospholipid syndrome

    Cross-sectional studyLupus & APS

  36. Rheumatology (Oxford)

    Multi-domain effectiveness of guselkumab evaluated via composite indices through 1 year in patients with PsA and inadequate response to TNFi: post hoc analysis of COSMOS

    Secondary analysisSpondyloarthritis & PsA

  37. Rheumatology (Oxford)

    Arthroscopy has a higher discriminative capacity than MRI in detecting mild cartilage lesions

    Diagnostic or prognostic studyOsteoarthritis

  38. Rheumatology (Oxford)

    Contributors to organ damage in childhood lupus: corticosteroid use and disease activity

    Cohort studyLupus & APS

  39. Rheumatology (Oxford)

    Infliximab vs interferon-α in the treatment of Behçet’s syndrome: clinical data from the BIO-BEHÇET’S randomized controlled trial

    Randomized controlled trialVasculitis & PMR

  40. Rheumatology (Oxford)

    ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (“Registry”)

    Cross-sectional studyLupus & APS

All 1,905 Briefs in ExploreShowing Briefs 841–880 of 1,905, newest first